Loading
Medmira Inc. has a thin disclosure history in our data (latest filing: 31 March 2021). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
1 of 1 declaration
Medmira Inc. is a Canadian company focused on developing rapid diagnostic tests for infectious diseases. It is listed on the XTSE market.